Claritev Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Claritev Corporation on March 5, 2025. The report details amendments to executive employment agreements and the establishment of new severance arrangements following an annual review of compensation. The company is incorporated in Delaware and its Class A Common Stock trades on the New York Stock Exchange under the symbol CTEV.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only specific financial figures disclosed relate to executive compensation:
- CEO Equity Grant (2025): Time-based restricted stock units with a grant date fair value of $2,670,000.
- CEO Cash-Settled RSUs (2025): Grant date fair value of $8,000,000.
Material Changes
Effective February 27 and 28, 2025, the Company executed the following material changes to executive compensation:
- CEO and CFO Agreements: Amended to provide enhanced severance upon termination without cause or resignation for good reason within one year of a change in control. The CEO is eligible for 2x base salary plus target bonus, while the CFO is eligible for 1.5x.
- Executive Severance Letters: Entered into agreements with four other executives (Jerome W. Hogge, Michael C. Kim, Tiffani D. Misencik, and Carol H. Nutter) providing severance of 0.5x to 1x base salary plus bonus upon termination without cause, increasing to 1x to 1.5x in a change in control scenario.
- 2025 Award Structure: Annual awards will consist of time-based RSUs (4-year vesting) and cash-settled RSUs (2-year vesting) with a cap of four times the grant date fair market value.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding business operations. The primary risks and contingencies disclosed relate to potential future liabilities associated with executive severance payments and equity vesting acceleration in the event of a change in control or specific terminations.
Investor Verification Checklist
- Verify the total potential cash liability for severance payments under the new agreements for the CEO, CFO, and other named executives.
- Confirm the specific vesting schedules and performance conditions for the $10.67 million in total CEO equity awards.
- Review the definition of "Change in Control" within the amended agreements to understand the triggers for accelerated vesting and enhanced severance.
- Assess the impact of these compensation changes on the company's future cash flow and equity dilution.